KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.
about
Surgical pathology of early stage non-small cell lung carcinomaClinical impacts of a micropapillary pattern in lung adenocarcinoma: a reviewCo-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomasImplementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should knowA comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotypeLung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFRSolid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence SurvivalAssociations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutationNuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltrationPredominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail?Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patientsAssociation between histopathological subtype, (18)F-fluorodeoxyglucose uptake and epidermal growth factor receptor mutations in lung adenocarcinoma.Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification.Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases.Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value.Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers.Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine-needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations.Classification of different patterns of pulmonary adenocarcinomas.KRAS-Mutant Lung Cancers in the Era of Targeted Therapy.Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer.Transition between morule-like and solid components may occur in solid-predominant adenocarcinoma of the lung: report of 2 cases with EGFR and KRAS mutationsMicropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.Inverse correlation between galectin-4 and TTF-1 in lung adenocarcinoma.Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene Alterations
P2860
Q26739713-EA1700E1-6F48-474D-9453-24C4E4D32D6BQ26771950-B946CAD9-4FCE-436E-922A-41ABDEC28FCCQ27345462-B4789C0C-B2D4-499C-944B-E2DA4C95DF43Q34141249-520ECDD9-1BC2-4F76-8C93-860C70622DEAQ34404229-D842441A-4298-4B90-B419-25E54C5C3F69Q34748124-1DD3628E-73F6-4F9E-8C2F-DE8E47FCA164Q35032336-1BD1A40A-EBCA-4079-A181-4500F6D4D248Q35741716-159AB88C-B0F5-47CC-92FE-D726CE760DC2Q35742165-5E332850-8BDE-4A41-899E-9C12CC894ECEQ36337437-DE24A790-F658-4CC7-860F-BF2579A21C99Q36413817-40F1823F-4396-4D59-B2BA-01838ECF6B70Q36474217-B087F4B7-79CC-4CF2-9643-60383722799EQ36477758-21C2E9BB-B2E7-4EAE-823B-FF4D4635EC94Q36640546-461EBDD6-D644-44C7-AB5C-99881AB414D5Q36741152-73FEB094-C4AD-45BB-9C66-4AAE8AC7CDD8Q36924440-B227D7CE-7589-46D0-B5CF-64344F70A792Q36952283-D503C1D0-E638-4CF5-B9DF-192C17CD5D11Q37269159-3E3AE5B8-ABA3-4EEC-88F5-C0139E4758F8Q38271717-3856FEB6-A92A-4960-95A3-B3E4C62B6080Q38574971-9084A7DF-1541-441A-895D-7CC85A970EACQ38669282-385D71E3-0A4C-4C14-AF59-FF72732D7A87Q38797202-548C8491-AABF-4A9B-8724-BB8FBA952F8BQ39626850-7DDF2EF4-7B31-4DCA-8353-7528B74BFBA6Q40070868-CBCA73A5-068C-4492-A8D8-4E41249FBCB8Q40542208-0AADBA62-625F-49B5-AAAC-8A0E352A3BADQ40559241-2D603429-60DC-4F02-8F21-D39D5DE66714Q41904659-37C1DBC9-5837-41BB-B4A2-261FDCDE4658Q48301301-67903E97-D766-4BBF-9EF8-80B1E4ED9954Q51823617-390FB16F-9650-4C6E-A5F6-3059710ADE6FQ58407647-D4DC3C82-90DA-41D5-B61B-1D8EAE355BFD
P2860
KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
KRAS mutations are associated ...... ocytes in lung adenocarcinoma.
@en
KRAS mutations are associated ...... ocytes in lung adenocarcinoma.
@nl
type
label
KRAS mutations are associated ...... ocytes in lung adenocarcinoma.
@en
KRAS mutations are associated ...... ocytes in lung adenocarcinoma.
@nl
prefLabel
KRAS mutations are associated ...... ocytes in lung adenocarcinoma.
@en
KRAS mutations are associated ...... ocytes in lung adenocarcinoma.
@nl
P2093
P2860
P1433
P1476
KRAS mutations are associated ...... ocytes in lung adenocarcinoma.
@en
P2093
Andre L Moreira
Daphne C Ang
Gregory J Riely
Natasha Rekhtman
P2860
P2888
P304
P356
10.1038/MODPATHOL.2013.74
P50
P577
2013-04-26T00:00:00Z